Artal Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,011,500
Closed -$8.11M 47
2024
Q2
$8.11M Buy
+1,011,500
New +$10.8M 0.21% 46
2021
Q2
Sell
-400,000
Closed -$12.7M 162
2021
Q1
$12.7M Hold
400,000
0.27% 88
2020
Q4
$18.6M Hold
400,000
0.42% 61
2020
Q3
$13.2M Sell
400,000
-100,000
-20% -$3.07M 0.43% 69
2020
Q2
$13.7M Sell
500,000
-250,000
-33% -$8.22M 0.47% 58
2020
Q1
$22.5M Buy
750,000
+250,000
+50% +$6.63M 1.07% 28
2019
Q4
$13.8M Sell
500,000
-200,000
-29% -$4.55M 0.58% 33
2019
Q3
$12.7M Hold
700,000
0.62% 40
2019
Q2
$17.2M Buy
700,000
+200,000
+40% +$3.01M 0.79% 31
2019
Q1
$4.75M Hold
500,000
0.23% 77
2018
Q4
$4.42M Sell
500,000
-200,000
-29% -$1.93M 0.22% 72
2018
Q3
$7.88M Hold
700,000
0.27% 61
2018
Q2
$8.96M Buy
700,000
+240,000
+52% +$3.51M 0.23% 51
2018
Q1
$7.77M Buy
+460,000
New +$6.97M 0.11% 57

Other funds holding IOVA